title: Second IASLC Workshop on combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Treatment evaluation.
authors.forename: H
authors.initials: H
authors.lastname: Hansen
authors.forename: M
authors.initials: M
authors.lastname: Perry
authors.forename: R
authors.initials: R
authors.lastname: Arriagada
authors.forename: C
authors.initials: C
authors.lastname: Chastang
authors.forename: P
authors.initials: P
authors.lastname: Drings
authors.forename: K
authors.initials: K
authors.lastname: Osterlind
authors.forename: M
authors.initials: M
authors.lastname: Parmar
authors.forename: J P
authors.initials: JP
authors.lastname: Pignon
authors.forename: N
authors.initials: N
authors.lastname: Thatcher
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015201:Meta-Analysis as Topic; D009367:Neoplasm Staging; D017063:Outcome Assessment, Health Care / Q000592:standards; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012042:Registries; D016019:Survival Analysis; D016896:Treatment Outcome